Brazil · Delayed Price · Currency is BRL Revance Therapeutics Statistics
Total Valuation
BVMF:GPAR3 has a market cap or net worth of BRL 1.82 billion. The enterprise value is 1.59 billion.
| Market Cap | 1.82B |
| Enterprise Value | 1.59B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BVMF:GPAR3 has 79.68 million shares outstanding. The number of shares has decreased by -0.69% in one year.
| Current Share Class | 79.68M |
| Shares Outstanding | 79.68M |
| Shares Change (YoY) | -0.69% |
| Shares Change (QoQ) | -0.31% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 54,875 |
Valuation Ratios
The trailing PE ratio is 55.44.
| PE Ratio | 55.44 |
| Forward PE | n/a |
| PS Ratio | 56.46 |
| PB Ratio | 2.31 |
| P/TBV Ratio | 2.33 |
| P/FCF Ratio | 221.67 |
| P/OCF Ratio | 73.12 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 48.36 |
| EV / Sales | 49.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 193.18 |
Financial Position
The company has a current ratio of 29.82, with a Debt / Equity ratio of 0.02.
| Current Ratio | 29.82 |
| Quick Ratio | 27.56 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.52 |
| Interest Coverage | -26.50 |
Financial Efficiency
Return on equity (ROE) is 4.25% and return on invested capital (ROIC) is -2.25%.
| Return on Equity (ROE) | 4.25% |
| Return on Assets (ROA) | -2.11% |
| Return on Invested Capital (ROIC) | -2.25% |
| Return on Capital Employed (ROCE) | -3.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.04 |
| Inventory Turnover | 99.94 |
Taxes
In the past 12 months, BVMF:GPAR3 has paid 8.85 million in taxes.
| Income Tax | 8.85M |
| Effective Tax Rate | 21.19% |
Stock Price Statistics
The stock price has decreased by -51.79% in the last 52 weeks. The beta is 0.09, so BVMF:GPAR3's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -51.79% |
| 50-Day Moving Average | 22.98 |
| 200-Day Moving Average | 31.02 |
| Relative Strength Index (RSI) | 14.78 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BVMF:GPAR3 had revenue of BRL 32.32 million and earned 32.88 million in profits. Earnings per share was 0.41.
| Revenue | 32.32M |
| Gross Profit | 17.18M |
| Operating Income | -28.41M |
| Pretax Income | 41.76M |
| Net Income | 32.88M |
| EBITDA | -27.98M |
| EBIT | -28.41M |
| Earnings Per Share (EPS) | 0.41 |
Balance Sheet
The company has 247.03 million in cash and 12.49 million in debt, giving a net cash position of 234.54 million or 2.94 per share.
| Cash & Cash Equivalents | 247.03M |
| Total Debt | 12.49M |
| Net Cash | 234.54M |
| Net Cash Per Share | 2.94 |
| Equity (Book Value) | 789.92M |
| Book Value Per Share | 9.91 |
| Working Capital | 291.70M |
Cash Flow
In the last 12 months, operating cash flow was 24.95 million and capital expenditures -16.72 million, giving a free cash flow of 8.23 million.
| Operating Cash Flow | 24.95M |
| Capital Expenditures | -16.72M |
| Free Cash Flow | 8.23M |
| FCF Per Share | 0.10 |
Margins
Gross margin is 53.15%, with operating and profit margins of -87.89% and 101.73%.
| Gross Margin | 53.15% |
| Operating Margin | -87.89% |
| Pretax Margin | 129.20% |
| Profit Margin | 101.73% |
| EBITDA Margin | -86.57% |
| EBIT Margin | -87.89% |
| FCF Margin | 25.47% |
Dividends & Yields
BVMF:GPAR3 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.01% |
| Buyback Yield | 0.69% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.80% |
| FCF Yield | 0.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |